FEB 07, 2018 9:00 AM PST

Animal Models for Tuberculosis Research

Speaker

Abstract

Tuberculosis (TB) is the No.1 cause of death due to a single infectious agent in the world today. According to the global report from World Health Organization, one third of world population is currently infected with Mycobacterium tuberculosis, the causative agent of tuberculosis. Approximately 90% of those infected have latent TB and therefore are not infectious and have no TB symptoms; however, the remaining ~10% will develop active tuberculosis at some time during their lifetime, resulting in an estimated 10 million new TB cases and ~2 million deaths worldwide annually. While the successful implementation of DOTS (Directly Observed Treatment, Short-course) strategy has significantly decreased the global TB spread in the past two decades, the development of multidrug-resistant (MDR) and extremely drug-resistant (XDR) TB is now becoming a serious concern in high burden populations. To accelerate the global control of TB and limit the spread of drug-resistant TB, more effective anti-TB vaccines and drug regimens are needed. Additionally, it’s clear that we need a better understanding of the interaction between the M. tuberculosis and its host at the cellular and organism level. To address these questions, suitable experimental animal models of TB are required that mimic the course of human TB as well as reproduce the human body responses to TB vaccines and drug regimens. In this Webinare, we will highlight the different animal models in TB medical research, and discuss the issues around the appropriate choice of animal model in understanding host-pathogen interaction mechanisms during an M. tuberculsis infection, and evaluation of anti-TB vaccines and drugs. 


Show Resources
You May Also Like
JUN 28, 2022 7:00 AM PDT
JUN 28, 2022 7:00 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUN 29, 2022 8:00 AM PDT
JUN 29, 2022 8:00 AM PDT
Date: June 29, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) As of May 2022, there have been more than 500 million confirmed cases of COVID-19, including numerous variants. Additiona...
AUG 17, 2022 10:00 AM PDT
AUG 17, 2022 10:00 AM PDT
DATE: October 22, 2020 TIME: 8:00am PDT, 11:00am EDT Detection and/or amplification of target DNA sequences by polymerase chain reaction (PCR) is a prevalent method in molecular biology. PCR...
JUN 01, 2022 9:00 AM PDT
JUN 01, 2022 9:00 AM PDT
Date: June 01, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) The manufacturing process for cell and gene therapies is complex and can contain process-related impurities from multiple...
FEB 07, 2018 9:00 AM PST

Animal Models for Tuberculosis Research



Show Resources
Loading Comments...
Show Resources